Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark P Rubinstein

Showing results (41-50 of 76) with videos related to

Pageof 8
Sort By:
Oncoimmunology|January 4, 2018
Sunitinib represses regulatory T cells to overcome immunotolerance in a murine model of hepatocellular cancerDai Liu, Guangfu Li, Diego M Avella, et al.
Frontiers in Immunology|March 8, 2019
Fueling Cancer Immunotherapy With Common Gamma Chain CytokinesConnor J Dwyer, Hannah M Knochelmann, Aubrey S Smith, et al.
Journal of the American College of Surgeons|February 25, 2012
Ex vivo interleukin-12-priming during CD8(+) T cell activation dramatically improves adoptive T cell transfer antitumor efficacy in a lymphodepleted hostMark P Rubinstein, Colleen A Cloud, Tracy E Garrett, et al.
European Journal of Immunology|May 9, 2020
Ex vivo blockade of PI3K gamma or delta signaling enhances the antitumor potency of adoptively transferred CD8<sup>+</sup> T cellsConnor J Dwyer, Dimitrios C Arhontoulis, Guillermo O Rangel Rivera, et al.
Cancer Research|May 7, 2013
Efficacy and mechanism-of-action of a novel superagonist interleukin-15: interleukin-15 receptor αSu/Fc fusion complex in syngeneic murine models of multiple myelomaWenxin Xu, Monica Jones, Bai Liu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 11, 2015
The inducible costimulator augments Tc17 cell responses to self and tumor tissueMichelle H Nelson, Sreenath Kundimi, Jacob S Bowers, et al.
Cancer Biology & Therapy|March 27, 2025
Sulfatase 2 inhibition sensitizes triple-negative breast cancer cells to paclitaxel through augmentation of extracellular ATPJasmine M Manouchehri, Jharna Datta, Lynn M Marcho, et al.
The Journal of Biological Chemistry|September 22, 2016
A Novel Fusion of ALT-803 (Interleukin (IL)-15 Superagonist) with an Antibody Demonstrates Antigen-specific Antitumor ResponsesBai Liu, Lin Kong, Kaiping Han, et al.
Journal for Immunotherapy of Cancer|August 25, 2025
Constructing the cure: engineering the next wave of antibody and cellular immune therapiesStefanie R Bailey, Eric Bartee, Kyle G Daniels, et al.
JCI Insight|April 20, 2017
β-catenin and PI3Kδ inhibition expands precursor Th17 cells with heightened stemness and antitumor activityKinga Majchrzak, Michelle H Nelson, Jacob S Bowers, et al.
Pageof 8

Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
Oncoimmunology|January 4, 2018
Sunitinib represses regulatory T cells to overcome immunotolerance in a murine model of hepatocellular cancerDai Liu, Guangfu Li, Diego M Avella, et al.
Frontiers in Immunology|March 8, 2019
Fueling Cancer Immunotherapy With Common Gamma Chain CytokinesConnor J Dwyer, Hannah M Knochelmann, Aubrey S Smith, et al.
Journal of the American College of Surgeons|February 25, 2012
Ex vivo interleukin-12-priming during CD8(+) T cell activation dramatically improves adoptive T cell transfer antitumor efficacy in a lymphodepleted hostMark P Rubinstein, Colleen A Cloud, Tracy E Garrett, et al.
European Journal of Immunology|May 9, 2020
Ex vivo blockade of PI3K gamma or delta signaling enhances the antitumor potency of adoptively transferred CD8<sup>+</sup> T cellsConnor J Dwyer, Dimitrios C Arhontoulis, Guillermo O Rangel Rivera, et al.
Cancer Research|May 7, 2013
Efficacy and mechanism-of-action of a novel superagonist interleukin-15: interleukin-15 receptor αSu/Fc fusion complex in syngeneic murine models of multiple myelomaWenxin Xu, Monica Jones, Bai Liu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 11, 2015
The inducible costimulator augments Tc17 cell responses to self and tumor tissueMichelle H Nelson, Sreenath Kundimi, Jacob S Bowers, et al.
Cancer Biology & Therapy|March 27, 2025
Sulfatase 2 inhibition sensitizes triple-negative breast cancer cells to paclitaxel through augmentation of extracellular ATPJasmine M Manouchehri, Jharna Datta, Lynn M Marcho, et al.
The Journal of Biological Chemistry|September 22, 2016
A Novel Fusion of ALT-803 (Interleukin (IL)-15 Superagonist) with an Antibody Demonstrates Antigen-specific Antitumor ResponsesBai Liu, Lin Kong, Kaiping Han, et al.
Journal for Immunotherapy of Cancer|August 25, 2025
Constructing the cure: engineering the next wave of antibody and cellular immune therapiesStefanie R Bailey, Eric Bartee, Kyle G Daniels, et al.
JCI Insight|April 20, 2017
β-catenin and PI3Kδ inhibition expands precursor Th17 cells with heightened stemness and antitumor activityKinga Majchrzak, Michelle H Nelson, Jacob S Bowers, et al.
Pageof 8